Abelson Helper Integration Site 1 (AHI1) (C-Term) Peptide
AHI1
Reactivity: Rat
Host: Synthetic
BP, WB
Quick Overview for Abelson Helper Integration Site 1 (AHI1) (C-Term) Peptide (ABIN973016)
Target
AHI1
(Abelson Helper Integration Site 1 (AHI1))
Origin
Rat
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- C-Term
-
Sequence
- KDSTLRIMDL RILAARKFVG AANYREKIHS TLTPCGTLLF SGSEDGIVYV
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-Ahi1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- AHI1 (Abelson Helper Integration Site 1 (AHI1))
-
Background
-
Mutations in the human homolog are associated with Joubert syndrome, an autosomal recessive disorder resulting in severe mental retardation.
Alias Symbols: Ahi-1, Ahi1
Protein Size: 1047 -
Molecular Weight
- 120 kDa
-
Gene ID
- 308923
-
NCBI Accession
- NM_001002277, NP_001002277
-
UniProt
- Q6DTM3
Target
-
You are here:
